[Migration and Tuberculosis]

Area of Science:

• Public Health
• Infectious Diseases
• Migration Health

Background:

• Tuberculosis (TB) predominantly affects migrants in Germany.
• Current screening under the German Protection against Infection Act (Infektionsschutzgesetz, IfSG) diagnoses only 20-25% of TB cases in migrants.
• Reactivation of latent TB is the primary cause of TB in migrant populations.

Purpose of the Study:

• To highlight challenges in diagnosing and treating tuberculosis in migrants.
• To emphasize the need for improved healthcare access for latent TB testing and treatment.
• To underscore the importance of addressing diverse risk factors, comorbidities, and socio-cultural aspects in migrant TB care.

Main Methods:

• Analysis of tuberculosis case data in Germany, focusing on the migrant demographic.
• Evaluation of the effectiveness of existing screening protocols (IfSG).
• Review of factors influencing TB presentation, diagnosis, and treatment in migrants, including country of origin, comorbidities, and migration-related stress.

Main Results:

• Screening methods under IfSG are insufficient for early TB detection in migrants.
• Latent TB reactivation is the most common form, necessitating accessible healthcare for testing and treatment.
• Extrapulmonary TB and multi-drug resistant TB require specific diagnostic considerations.
• Cultural and linguistic barriers, alongside trust issues, impede effective doctor-patient relationships and treatment adherence.

Conclusions:

• Enhanced healthcare access and tailored diagnostic approaches are vital for managing TB in migrants.
• Building trust through empathy and cultural sensitivity is essential for successful treatment completion.
• Addressing comorbidities and socio-legal factors is crucial for comprehensive TB care in this population.